108 related articles for article (PubMed ID: 3087015)
1. Plasminogen activator inhibitors in plasma and platelets from patients with recurrent venous thrombosis and pregnant women.
Häggroth L; Mattsson C; Felding P; Nilsson IM
Thromb Res; 1986 Jun; 42(5):585-94. PubMed ID: 3087015
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma.
Jørgensen M; Philips M; Thorsen S; Selmer J; Zeuthen J
Thromb Haemost; 1987 Oct; 58(3):872-8. PubMed ID: 3124286
[TBL] [Abstract][Full Text] [Related]
3. Catabolism of tissue-type plasminogen activator by the human hepatoma cell line Hep G2. Modulation by plasminogen activator inhibitor type 1.
Morton PA; Owensby DA; Sobel BE; Schwartz AL
J Biol Chem; 1989 May; 264(13):7228-35. PubMed ID: 2540181
[TBL] [Abstract][Full Text] [Related]
4. The formation of complexes between human plasminogen activator inhibitor-1 (PAI-1) and sodium dodecyl sulfate: possible implication in the functional properties of PAI-1.
Gaussem P; Anglés-Cano E
Biochim Biophys Acta; 1991 Sep; 1079(3):321-9. PubMed ID: 1911857
[TBL] [Abstract][Full Text] [Related]
5. Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor.
Schleef RR; Higgins DL; Pillemer E; Levitt LJ
J Clin Invest; 1989 May; 83(5):1747-52. PubMed ID: 2496147
[TBL] [Abstract][Full Text] [Related]
6. Different types of plasminogen activator inhibitors in plasma and platelets in pregnant women.
Nilsson IM; Felding P; Lecander I; Lennér C; Astedt B
Br J Haematol; 1986 Feb; 62(2):215-20. PubMed ID: 3484963
[TBL] [Abstract][Full Text] [Related]
7. Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis.
Jørgensen M; Bonnevie-Nielsen V
Br J Haematol; 1987 Feb; 65(2):175-80. PubMed ID: 3103670
[TBL] [Abstract][Full Text] [Related]
8. Identification and partial characterization by chemical cross-linking of a binding protein for tissue-type plasminogen activator (t-PA) on rat hepatoma cells. A plasminogen activator inhibitor type 1-independent t-PA receptor.
Bu G; Morton PA; Schwartz AL
J Biol Chem; 1992 Aug; 267(22):15595-602. PubMed ID: 1322401
[TBL] [Abstract][Full Text] [Related]
9. Sodium dodecyl sulfate-induced dissociation of complexes between human tissue plasminogen activator and its specific inhibitor.
Gaussem P; Grailhe P; Anglés-Cano E
J Biol Chem; 1993 Jun; 268(16):12150-5. PubMed ID: 8505335
[TBL] [Abstract][Full Text] [Related]
10. The release of plasminogen activators (t-PA and u-PA) and plasminogen activator inhibitor (PAI-1) after venous stasis.
Falkon L; Garí M; Borrell M; Fontcuberta J
Blood Coagul Fibrinolysis; 1992 Feb; 3(1):33-8. PubMed ID: 1623118
[TBL] [Abstract][Full Text] [Related]
11. Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor.
Thorsen S; Philips M
Biochim Biophys Acta; 1984 Nov; 802(1):111-8. PubMed ID: 6435684
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).
Declerck PJ; De Mol M; Alessi MC; Baudner S; Pâques EP; Preissner KT; Müller-Berghaus G; Collen D
J Biol Chem; 1988 Oct; 263(30):15454-61. PubMed ID: 2459123
[TBL] [Abstract][Full Text] [Related]
13. Studies on the release of a plasminogen activator inhibitor by human platelets.
Kruithof EK; Tran-Thang C; Bachmann F
Thromb Haemost; 1986 Apr; 55(2):201-5. PubMed ID: 2940723
[TBL] [Abstract][Full Text] [Related]
14. Immunological relationship between the fast-acting plasminogen activator inhibitors from plasma, blood platelets and endothelial cells demonstrated with a monoclonal antibody against an inhibitor from placenta.
Philips M; Juul AG; Thorsen S; Selmer J; Zeuthen J
Thromb Haemost; 1986 Apr; 55(2):213-7. PubMed ID: 2424117
[TBL] [Abstract][Full Text] [Related]
15. Presence of active and latent type 1 plasminogen activator inhibitor associated with porcine platelets.
Lang IM; Marsh JJ; Moser KM; Schleef RR
Blood; 1992 Nov; 80(9):2269-74. PubMed ID: 1421397
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma.
Verheijen JH; Chang GT; Kluft C
Thromb Haemost; 1984 Jul; 51(3):392-5. PubMed ID: 6437006
[TBL] [Abstract][Full Text] [Related]
17. Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activator.
Keijer J; Ehrlich HJ; Linders M; Preissner KT; Pannekoek H
J Biol Chem; 1991 Jun; 266(16):10700-7. PubMed ID: 1709939
[TBL] [Abstract][Full Text] [Related]
18. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation.
Kruithof EK; Nicolosa G; Bachmann F
Blood; 1987 Nov; 70(5):1645-53. PubMed ID: 3117137
[TBL] [Abstract][Full Text] [Related]
20. Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay.
Eriksson E; Rånby M; Gyzander E; Risberg B
Thromb Res; 1988 Apr; 50(1):91-101. PubMed ID: 3135638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
